Press Room
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Effective May 1st, 2020
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Hovione celebrates its 60th Anniversary in Cork
Loughbeg, Co. Cork. Thursday, September 5th, 2019: Hovione is celebrating its 60th Anniversary today in its site in Cork.
Hovione issues $50 million bond
Hovione has issued a bond of $50 million US dollars maturing in 2033.
Hovione increases production capacity
‘One Site Shop’ expands to respond to growing demands
Hovione reports on recent capacity expansion and future plans to support growth
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Compliance at Hovione - Annual Inspection Review
Hovione announced today that in the last year their manufacturing facilities were the object of eight inspections, performed by different Health Authorities.
Hovione sells the iMAX business
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
Hovione strengthens Inhalation Services portfolio
Hovione announced that a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities